Invasive Mapping News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nexstim Oyj: Nexstim Plc Business and Clinical Update Q1 2021 Q1 2021 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the key highlights of the Company's business and clinical progress during Q1 2021. CEO Mikko Karvinen's pdate Glad to inform that our operational business has had the best start of the year ever while beginning our first full year of executing our renewed strategy. During the first months of 2021, we have continued to invest in the growth of our diagnostic and therapeutic business with the recruitment of two new sales team members to our US organization...

Press release, Helsinki, 13 January 2021 at 13.00 New Study Presents Impressive Results of Nexstim SmartFocus® nTMS Language Mapping Nexstim Plc announces that a new study published in... | January 14, 2021

Nexstim Oyj: New Study Presents Impressive Results of Nexstim SmartFocus nTMS Language Mapping New Study Presents Impressive Results of Nexstim SmartFocus nTMS Language Mapping Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that a new study published in Cancers in January presents impressive results of nTMS language mapping in a large amount of patients. Using the robustness of Nexstim SmartFocus nTMS data, the authors also introduce a new and more precise classification of what it means to be a "language eloquent" tumour, challenging the traditional methods that seek ...